INNOSPEC INC.
For the period ended Sep 30, 2025. Filed Nov 5, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2025 · Filed Nov 5, 2025
IOSP$80.21+2.6%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Balance Sheets
| (in millions, except share and per share data) | September 30,2025 | December 31,2024 |
|---|---|---|
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $270.8 | $289.2 |
| Trade and other accounts receivable (less allowances of $9.8 million and $11.9 million respectively) | 349.5 | 341.7 |
| Inventories (less allowances of $39.4 million and $34.6 million respectively): | ||
| Finished goods | 236.3 | 197.9 |
| Raw materials | 108.9 | 103.1 |
| Total inventories | 345.2 | 301.0 |
| Prepaid expenses | 8.7 | 21.0 |
| Prepaid income taxes | 10.5 | 3.1 |
| Other current assets | 4.1 | 0.6 |
| Total current assets | 988.8 | 956.6 |
| Net property, plant and equipment | 278.6 | 269.7 |
| Operating lease right-of-use assets | 49.0 | 44.8 |
| Goodwill | 399.8 | 382.5 |
| Other intangible assets | 63.3 | 65.4 |
| Deferred tax assets | 8.9 | 9.4 |
| Pension asset | — | 2.4 |
| Other non-current assets | 11.0 | 3.9 |
| Total assets | $1,799.4 | $1,734.7 |
| Liabilities and Equity | ||
|---|---|---|
| Current liabilities: | ||
| Accounts payable | $162.2 | $163.8 |
| Accrued liabilities | 167.3 | 169.1 |
| Current portion of operating lease liabilities | 16.0 | 13.9 |
| Current portion of plant closure provisions | 5.0 | 5.0 |
| Accrued income taxes | 5.6 | 19.6 |
| Total current liabilities | 356.1 | 371.4 |
| Operating lease liabilities, net of current portion | 33.0 | 31.0 |
| Plant closure provisions, net of current portion | 63.2 | 55.3 |
| Deferred tax liabilities | 14.1 | 23.5 |
| Pension liabilities and post-employment benefits | 13.8 | 13.1 |
| Acquisition-related contingent consideration | 8.2 | 20.1 |
| Other non-current liabilities | 8.1 | 4.2 |
| Total liabilities | 496.5 | 518.6 |
| Equity: | ||
| Common stock, $0.01 par value, authorized 40,000,000 shares, issued 29,554,500 shares | 0.3 | 0.3 |
| Additional paid-in capital | 373.6 | 369.9 |
| Treasury stock (4,776,918 and 4,594,943 shares at cost, respectively) | (115.3) | (93.0) |
| Retained earnings | 1,073.4 | 1,025.0 |
| Accumulated other comprehensive loss | (35.0) | (91.0) |
| Total Innospec stockholders’ equity | 1,297.0 | 1,211.2 |
| Non-controlling interest | 5.9 | 4.9 |
| Total equity | 1,302.9 | 1,216.1 |
| Total liabilities and equity | $1,799.4 | $1,734.7 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.